Anastasiya Vladimirovna Belyatskaya

Anastasiya Vladimirovna Belyatskaya

Auto-generated profile, based on publicly available information

Anastasiya Vladimirovna Belyatskaya

Sechenov First Moscow State Medical University (Sechenov University)

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2019 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
ABA. V. Belyatskaya
A. V. Belyatskaya
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
OSO. I. Stepanova
O. I. Stepanova
TKT. M. Kosheleva
T. M. Kosheleva
TKT. P. Kudinova
T. P. Kudinova
MMM. M. Maryanyan
M. M. Maryanyan

1 January 2020 in Moscow University Chemistry Bulletin
Verified
Journal Article
Closed access
PDF file
ABA. V. Beliatskaya
A. V. Beliatskaya
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
AEA. O. Elagina
A. O. Elagina
IKI. M. Kashlikova
I. M. Kashlikova
OSO. I. Stepanova
O. I. Stepanova
DKD. R. Kannieva
D. R. Kannieva
The effect of solid dispersions (SDs) on the solubility of furazolidone is studied. Furazolidone and its SDs with polyvinylpyrrolidone (PVP), PVP-10

19 August 2021 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
SNS. R. Naryshkin
S. R. Naryshkin
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
ABA. V. Belyatskaya
A. V. Belyatskaya
OSO. I. Stepanova
O. I. Stepanova
AVAlexander Vorobyev
Alexander Vorobyev
The aim of the work is to study the effect of solid dispersions using polyethylene glycols of various molecular weights on the solubility of metronidazole in water. Metronidazole is an antimicrobial and antiprotozoal drug. Its low solubility in water limits the use of metronidazole, causing technological difficulties and reducing its bioavailability. The solubility and release of the active substance from dosage forms can be increased using the solid dispersion methods. Solid dispersions are bi- or multicomponent systems consisting of an active substance and a carrier (a highly dispersed solid phase of the active substance or molecular-dispersed solid solutions) with a partial formation of complexes of variable compositions with the carrier material.Materials and methods. The substance of metronidazole used in the experiment, was manufactured by Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (China). To obtain solid dispersions, polyethylene glycols of various molar masses – 1500, 2000 and 3000 g/mol – were used. The solid dispersions were prepared by “the solvent removal method”: metronidazole and the polymer were dissolved in a minimum volume of 96% ethyl alcohol (puriss. p.a./analytical grade) at 65±2°C, and then the solvent was evaporated under vacuum to the constant weight. A vacuum pump and a water bath were used at the temperature of 40±2°C. The dissolution of the samples was studied using a magnetic stirrer with heating, and a thermostatting device. The concentration of metronidazole was determined on a spectrophotometer using quartz cuvettes at the wavelength of 318±2 nm. To filter the solutions, syringe nozzles were used, the pores were 0.45 μm, the filter was nylon. Microcrystalloscopy was performed using a microscope with a digital camera. The optical properties of the solutions were investigated using a quartz cuvette and a mirror camera (the image exposure – 20 sec).Results. Obtaining solid dispersions increases the completeness and rate of the metronidazole dissolution. The solubility of metronidazole from solid dispersions increases by 14–17% in comparison with the original substance. The complex of physical-chemical methods of the analysis, including UV spectrophotometry, microcrystalloscopy and the study of the optical properties of the obtained solutions, makes it possible to suggest the following. The increase in the solubility of metronidazole from solid dispersions is explained by the loss of crystallinity and the formation of a solid solution of the active substance and the solubilizing effect of the polymer with the formation of colloidal solutions of metronidazole at subsequent dissolution of the solid dispersion in water.Conclusion. The preparation of solid dispersions with polyethylene glycols improves the dissolution of metronidazole in water. The results obtained are planned to be used in the development of rapidly dissolving solid dosage forms of metronidazole with an accelerated release and an increased bioavailability.

1 March 2019 in Moscow University Chemistry Bulletin
Verified
Journal Article
Closed access
PDF file
ABA. V. Beliatskaya
A. V. Beliatskaya
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
OSO. I. Stepanova
O. I. Stepanova
ZAZ. A. Abgaryan
Z. A. Abgaryan
TKT. P. Kudinova
T. P. Kudinova
INI. S. Nesterenko
I. S. Nesterenko
The solubility of ketoprofen (nonsteroidal anti-inflammatory drug) from solid dispersions based on polyvinylpyrrolidone (PVP-10000, PVP-12600 and PVP-24000) is studied. The use of solid dispersions...

1 May 2025 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
IMIosif B. Mikhel
Iosif B. Mikhel
EBElena Bakhrushina
Elena Bakhrushina
OSOlga Stepanova
Olga Stepanova
SPSofiya Prilepskaya
Sofiya Prilepskaya
DKDmitriy Kosenkov
Dmitriy Kosenkov
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
Ribavirin has been used as an antiviral agent to treat a variety of viral infections since the 1970s. Over the past few decades, studies have been conducted on the pharmacology of ribavirin, and the possibility of its use in new indications has been explored. According to the results of a number of studies, ribavirin efficacy in the therapy of malignant neoplasms of various genesis has been proven. Furthermore, due to the complexity of brain tumor therapy using surgical methods, targeted delivery of ribavirin to the brain becomes a promising alternative to existing treatment methods. Targeting of active pharmaceutical ingredient (API) to the brain tumor is achieved by intranasal drug delivery via a Nose-to-Brain mechanism. In addition, using this delivery mechanism, it is possible to reach the brain while bypassing the blood-brain barrier (BBB), thus avoiding the effects of the first passage through the liver. Despite the significant advantages of the method, there are limiting factors to its application - mucociliary clearance, which aims to remove foreign bodies from the surface of the nasal mucosa. In situ, systems are able to reduce the intensity of interfering factors on API and allow the achievement of maximum bioavailability during intranasal administration.

6 March 2022 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
AEA. O. Elagina
A. O. Elagina
ABA. V. Belyatskaya
A. V. Belyatskaya
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
OSO. I. Stepanova
O. I. Stepanova
Julietta V. RauJulietta V. Rau
Julietta V. Rau
Taking into account the current Product specification file, the aim of the work was to develop the composition and technology for obtaining effervescent tablets based on solid dispersions of furazolidone in the form of an aqueous solution for external use.Materials and methods. The used substances were: furazolidone, anhydrous sodium carbonate (chemically pure), polyvinylpyrrolidone-24000±2000 (chemically pure), malic acid (analytically pure), tartaric acid (chemically pure), citric acid (chemically pure), sodium benzoate (chemically pure), ethyl alcohol 96% (chemically pure), purified water. Preparation of granulates is separate wet granulation in a fluidized bed (Mycrolab, BOSCH, Germany). Obtaining tablets is the process of pressing on a manual hydraulic test press (“PRG”, VNIR, Russia). The dependence of disintegration, abrasion capacity and crushing resistance on compacting pressure was investigated. Technological parameters of granulates, еру obtained effervescent tablets, shelf life and storage conditions were investigated according to the State Pharmacopoeia of the Russian Federation XIVth ed.Results. Two compositions of effervescent tablets containing solid dispersions of furazolidone as an active substance were obtained, which, when dissolved in 100 ml of water at room temperature (20°C), form a solution of furazolidone with a concentration of 0.004% in less than 5 minutes. The method of quantitative determination of the furazolidone content in the effervescent tablets was validated. A complex of physicochemical methods for the analysis of tablets was carried out. Quality standards have been developed. The developed compositions stability of instant tablets during storage during accelerated and long-term tests has been experimentally confirmed. The preliminary shelf life and storage conditions have been determined.Conclusion. The result of technological and chemical-pharmaceutical research is the creation and evaluation of the quality of a new instant furazolidone dosage form as effervescent tablet formulations.